PDUFA/BsUFA VII HIRING AND RETENTION ASSESSMENT
Closed Special Notice Posted
- Solicitation number
- 75F40123R00127
- Agency
-
Office of Operations
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541618 Other Management Consulting Services
- Place of performance
- Silver Spring, Maryland 20993, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The US Food and Drug Administration (FDA) intends to award a sole source contract to ERG for assessing all aspects of HR/HC operations and transformation, and preparing an assessment that expands on the initial, interim, and final assessments of hiring and retention in HR/HC components of FDA. The contract will be performed at the FDA's office in Silver Spring, MD. Interested parties have seven days after the publication of this notice to express their interest and capabilities.
List of Services:
- Assessment of all aspects of HR/HC operations and transformation.
- Preparation of an expanded assessment of the initial, interim, and final assessments of hiring and retention in HR/HC components of FDA.
Notice text
Notice of Intent Sole Source
This announcement is not a Request for Proposal.
The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to award a sole source award to ERG, a current incumbent contract holder; in assessing all aspects of HR/HC operations and transformation to prepare an assessment that expands on the initial baseline, interim, and final assessments of the hiring and retention in HR/HC components of
FDA; at the US Food and Drug Administration 10903 New Hampshire Avenue Building 66 Silver Spring MD 20993.
The propose simplified acquisition is for services; the Government intends to solicit and negotiate to only one source. Interested parties may identify their interests and capabilities to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to compete this proposed simplified acquisition based upon responses to this notice, is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive requirement. No further solicitation is available.
FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by 08/08/23, 12:00 PM EST.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| FDA/CDRH Scientific Technical Capacity for Regulatory Review | FDA Office of Acquisition and Grant Services | No set-aside | |
| FDA Scientific & Regulatory Support Services(SRS) | FDA Office of Acquisition and Grant Services | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity